No Data
No Data
No Data
No Data
No Data
Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results
VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already
AccesswireApr 22 09:00 ET
Express News | ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences
Moomoo 24/7Apr 12 09:03 ET
Express News | EXCLUSIVE: ImmunoPrecise Antibodies Tells Benzinga 'This Collaboration Integrates the New Vector Search Capability of the InterSystems IRIS Data Platform With IPA's Subsidiary BioStrand's LENS Platform for AI-driven Applications in Healthcare'
Moomoo 24/7Mar 28 06:45 ET
Express News | EXCLUSIVE: ImmunoPrecise Antibodies Tells Benzinga Co's Subsidiary BioStrand And InterSystems Announce A Collaboration For AI-Driven Healthcare Applications
Moomoo 24/7Mar 28 06:45 ET
ImmunoPrecise Antibodies Acquires Carterra LSA Instrument
Seeking AlphaMar 20 07:36 ET
Express News | IPA Acquires The Carterra LSA Instrument to Enhance Antibody Discovery And Bolster Its AI Developments
Moomoo 24/7Mar 20 07:03 ET
loading...
No Data
No Data